Fingerprint
Dive into the research topics of 'Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): An international, multicentre, randomised, placebo-controlled, phase 3 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically